Clinical Study
Feasibility and Safety of Perilla Seed Oil as an Additional Antioxidative Therapy in Patients with Mild to Moderate Dementia
Table 3
Patients enrolled to the study and dropped out from the study divided by subtypes of dementia.
| | Volunteers according to the type of dementia enrolled | | Alzheimer’s disease () | Vascular dementia () | Parkinson’s disease with dementia () | Mixed dementia () | Other dementia () |
| | Perilla seed oil | 94 (51.65) | 49 (56.98) | 32 (47.06) | 8 (44.44) | 2 (66.66) | 3 (42.86) | | Placebo | 88 (48.35) | 37 (43.02) | 36 (52.94) | 10 (55.55) | 1 (33.33) | 4 (57.14) | | Volunteers according to the type of dementia drop-out | | Alzheimer’s disease | Vascular dementia | Parkinson’s disease with dementia | Mixed dementia | Other dementia | | Perilla seed oil | 27 (47.37) | 15 (55.55) | 6 (22.22) | 3 (11.11) | 1 (3.70) | 2 (7.41) | | Placebo | 30 (52.60) | 12 (40.00) | 11 (36.66) | 3 (10.00) | 0 (0.00) | 4 (13.33) |
|
|
